A study conducted in 2014 was the first to identify increased formation of NETs in DM/PM patients, as well as incomplete degradation of over-formed NETs due to reduced deoxyribonuclease I (DNase I) activity in ILD patients. This evidence concerns the gene DNASE1 and dermatomyositis.